Litcius/Paper detail

Effectivity and safety of PD-1/PD-L1 inhibitors for different level of PD-L1-positive, advanced NSCLC: A meta-analysis of 4939 patients from randomized controlled trials

Yuanchao Shi, Jingwei Duan, Quanlin Guan, Penglong Xue, Ya Zheng

2020International Immunopharmacology11 citationsDOI

Topics & Concepts

Randomized controlled trialMeta-analysisMedicineInternal medicineOncologyPD-L1ImmunotherapyCancerCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Diagnosis and Treatment
Effectivity and safety of PD-1/PD-L1 inhibitors for different level of PD-L1-positive, advanced NSCLC: A meta-analysis of 4939 patients from randomized controlled trials | Litcius